Hanna Ritzén
Hanna holds an MBA and a Bachelor of Science in Engineering in Chemistry and Biotechnology from Uppsala University. She has over 20 years of experience in life sciences, with senior leadership roles in Research and Development, focusing on assay development for academia, pharmaceutical companies, CROs, and clinical diagnostics. She has led multiple product development programs and launches of RUO and IVD assays, and implemented robust processes across innovation, product development, and customer support.
Holdings: 15 700 Class B shares.
Stock options: 50 400 LTIP instruments
>4,500
Numbers of patients in studies
28
Publications
32
Pharma Projects